Operating Lease, Right-of-Use Asset in USD of LUMOS PHARMA, INC. from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Lumos Pharma, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2018 to Q3 2024.
  • Lumos Pharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $187K, a 30.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

LUMOS PHARMA, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2024 $187K -$81K -30.2% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $463K +$118K +34.2% Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $534K +$114K +27.1% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $603K +$373K +162% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $268K Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $345K Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $420K Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $230K -$326K -58.6% Dec 31, 2022 10-K 2024-03-07
Q4 2021 $556K Dec 31, 2021 10-K 2023-03-07
Q4 2019 $735K -$6.77M -90.2% Dec 31, 2019 10-K 2020-03-03
Q4 2018 $7.5M Jan 1, 2019 10-Q 2019-11-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.